Katia Boven

3.6k citations

36 papers · 2.7k indexed · 1 hit paper · h-index 23

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 15
- HIV Research and Treatment 15
Infectious Diseases 23
- HIV/AIDS drug development and treatment 22
- HIV/AIDS Research and Interventions 11

Co-authors: L Rimsky Simon Vanveggel Herta Crauwels Bonaventura Clotet Johan Vingerhoets Gastón Picchio Jean‐Michel Molina Beatriz Grinsztejn
Journals: Journal of the International AIDS Society (5 papers)Antiviral Therapy (3 papers)AIDS (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)HIV Medicine (2 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

Katia Boven

36 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family 1997 · 467 citations

Peers

Countries citing papers authored by Katia Boven

Since Specialization

Citations

This map shows the geographic impact of Katia Boven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Boven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Boven more than expected).

Fields of papers citing papers by Katia Boven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Boven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Boven. The network helps show where Katia Boven may publish in the future.

Co-authors

The 25 scholars most cited alongside Katia Boven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katia Boven Line = papers co-authored together Katia Boven links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir Drugs in R&D ·Magda Opsomer, Dessislava I. Dimitrova, J. Verspeelt, Amy Purrington, A. Mehbob, Scott Chavers, Helen Pai, Simon Vanveggel, Donghan Luo, Kimberley Brown, Christiane Moecklinghoff, Richard E. Nettles, Katia Boven	2018	9
2	Change in Vitamin D Levels and Risk of Severe Vitamin D Deficiency over 48 Weeks among HIV-1-Infected, Treatment-Naive Adults Receiving Rilpivirine or Efavirenz in a Phase III Trial (Echo) Antiviral Therapy ·David A. Wohl, Chloe Orkin, Manuela Doroana, José Henrique Pilotto, Somnuek Sungkanuparph, Patrick Yéni, Simon Vanveggel, H. Deckx, Katia Boven	2013	36
3	Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials Journal of Antimicrobial Chemotherapy ·Mark Nelson, G. Amaya, Nathan Clumeck, C Arns Da Cunha, D. Jayaweera, Patrice Junod, T. Li, Pablo Tebas, Marita Stevens, Annemie Buelens, Simon Vanveggel, Katia Boven, (unknown)	2012	30
4	Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials AIDS ·Calvin Cohen, Jean‐Michel Molina, Isabel Cassetti, Ploenchan Chetchotisakd, Adriano Lazzarin, Chloe Orkin, Frank S. Rhame, Hans-Jürgen Stellbrink, Taisheng Li, Herta Crauwels, L Rimsky, Simon Vanveggel, Peter Williams, Katia Boven	2012	103
5	Pre-Existing Mutations in the Rilpivirine Phase Iii Trials Echo and Thrive: Prevalence and Impact on Virological Response Antiviral Therapy ·Johan Vingerhoets, L Rimsky, Veerle Van Eygen, Steven Nijs, Simon Vanveggel, Katia Boven, Gastón Picchio	2012	31
6	Effect of gender and race on the week 48 findings in treatment‐naïve, HIV‐1‐infected patients enrolled in the randomized, phase III trials ECHO and THRIVE HIV Medicine ·Sally Hodder, Keikawus Arastéh, Joseph de Wet, Joseph Gathe, Julian Gold, Princy Kumar, Lerato Mohapi, William R. Short, Herta Crauwels, Simon Vanveggel, Katia Boven	2012	35
7	Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial The Lancet ·Calvin Cohen, Jaime Andrade‐Villanueva, Bonaventura Clotet, Jan Fourie, Margaret Johnson, Kiat Ruxrungtham, Hao Wu, Carmen Zorrilla, Herta Crauwels, L Rimsky, Simon Vanveggel, Katia Boven	2011	286
8	Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents AIDS ·Christoph Königs, Cornelia Feiterna‐Sperling, Susanna Esposito, Claudio Viscoli, Raffaella Rosso, Thomas N. Kakuda, Ruud Leemans, Monika Peeters, Rebecca Mack, Ingeborg Peeters, Rekha Sinha, Katia Boven, Carlo Giaquinto	2011	13
9	Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial The Lancet ·Jean‐Michel Molina, Pedro Cahn, Beatriz Grinsztejn, Adriano Lazzarin, Anthony Mills, Michael S. Saag, Khuanchai Supparatpinyo, Sharon Walmsley, Herta Crauwels, L Rimsky, Simon Vanveggel, Katia Boven	2011	315
10	Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies JAIDS Journal of Acquired Immune Deficiency Syndromes ·L Rimsky, Johan Vingerhoets, Veerle Van Eygen, Joseph J. Eron, Bonaventura Clotet, Annemie Hoogstoel, Katia Boven, Gastón Picchio	2011	133
11	Pooled Week 96 efficacy, resistance and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV, TMC278) versus efavirenz (EFV) in treatment-naïve, HIV-1-infected adults Calvin Cohen, CJ Cohen, Jean‐Michel Molina, Isabel Cassetti, Ploenchan Chetchotisakd, Adriano Lazzarin, Frank S. Rhame, HJ Stellbrink, Liang Tai-sheng, Herta Crauwels, L Rimsky, Simon Vanveggel, Paulette Williams, Katia Boven, Helios Salud	2011	13
12	Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial AIDS ·Anton Pozniak, Javier O Morales-Ramirez, Elly Katabira, Dewald Steyn, Sergio Lupo, Mario Santoscoy, Beatriz Grinsztejn, Kiat Ruxrungtham, L Rimsky, Simon Vanveggel, Katia Boven	2009	89
13	Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care Unit American Journal of Respiratory and Critical Care Medicine ·Scot T. Bateman, Jacques Lacroix, Katia Boven, Peter Forbes, Roger P. Barton, Neal J. Thomas, Brian R. Jacobs, Barry P. Markovitz, Brahm Goldstein, James Hanson, H. Agnes Li, Adrienne G. Randolph	2008	206
14	Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery Nephrology Dialysis Transplantation ·Katia Boven, John Knight, F. E. Bader, Jérôme Rossert, Kai‐Uwe Eckardt, Nicole Casadevall	2005	66
15	The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes Kidney International ·Katia Boven, Scott Stryker, John Knight, Adrian G. Thomas, Marc Van Regenmortel, D.M. Kemeny, David A. Power, Jérôme Rossert, Nicole Casadevall	2005	149
16	Progressive pseudorheumatoid dysplasia European Radiology ·S. Mampaey, Filip Vanhoenacker, Katia Boven, Wim Van Hul, A. De Schepper	2000	25
17	A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family Nature Genetics ·Sonia Abdelhak, Vasiliki Kalatzis, Roland Heilig, Sylvie Compain, Delphine Samson, C. Vincent, Dominique Weil, Corinne Cruaud, Iman Sahly, Michel Leibovici, Maria Bitner‐Glindzicz, Mary C. Francis, Didier Lacombe, Jacqueline Vigneron, R Charachon, Katia Boven, P Bedbeder, Nicole Van Regemorter, Jean Weissenbach, Christine Petit Hit paper breakdown →	1997	467
18	Anti-glomerular basement membrane glomerulopathy in a young child Pediatric Nephrology ·Katia Boven, Hielko Miljoen, Koen J. Van Hoeck, Eric A. Van Marck, K. J. Van Acker	1996	9
19	Atypical kawasaki disease: An often missed diagnosis European Journal of Pediatrics ·Katia Boven, E R de Graeff-Meeder, Wim G.M. Spliet, W. Kuis	1992	23
20	Idiopathic arterial calcification of infancy Calcified Tissue International ·Patrick J. Van Reempts, Katia Boven, Silja E.C. Spitaels, A. M. Roodhooft, E. L. J. Vercruyssen, K. J. Van Acker	1991	21

About Katia Boven

Katia Boven is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Nephrology and Hematology, having authored 36 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (22 papers), HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (11 papers), HIV-related health complications and treatments (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Pharmaceutical studies and practices (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Biochemical and Molecular Research (3 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (1.6k citations), Emergency Medicine (305 citations), Biochemistry (140 citations) and Sensory Systems (85 citations). Katia Boven has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include L Rimsky, Simon Vanveggel, Herta Crauwels, Bonaventura Clotet, Johan Vingerhoets, Gastón Picchio, Jean‐Michel Molina, Beatriz Grinsztejn, Calvin Cohen and Jan Fourie. Their work appears in journals such as Journal of the International AIDS Society, Antiviral Therapy, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes and HIV Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact